KRMD Company Profile and Key Details

KORU Medical Systems, Inc. has 46.23 million shares outstanding. The public float is 33.83 million shares, elevated short interest at 4.45% of float. This equals 1.38 million shares. The short ratio is 9.0 days. Institutional investors hold 60.12% of the float. Insiders own 7.64%. Horton Freedom, L.P. holds 7.39 million shares, Manko Joseph M. Jr. has 2.20 million shares and Tharby Linda M has 1.06 million shares.

Short-term trend indicators are mixed aligned (SMA20 0.8%, SMA50 -8.8%, SMA200 15.56%). The stock’s 14-day RSI is 47.38 (neutral), while the ATR of 0.28 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -25.09% below its high and over 166.13% above its low. Average 10-day trading volume of 196.22 thousand shares is slightly above the 3-month average of 160.05 thousand, indicating heightened recent market interest.

The latest quarter delivered EPS of -$0.02. The next quarter is forecast at -$0.02. Next year's EPS is expected at $19.78. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $8.00 to $6.00. The high target offers 105.13% upside. The low target suggests 53.85% downside. The mean target is $7.00. This offers 79.49% upside. KORU Medical Systems, Inc. earnings surprise history is a mixed track record. The quarter that ended May 06, 2026, missed forecasts by 0.0%. The prior quarter beat by -50.0%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in March 12, 2025.

KORU Medical Systems, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$3.95. This means the shares are trading below this model’s fair value.

KORU Medical Systems, Inc. (NASDAQ:KRMD) closed at $3.90 USD, losing -$0.08 (-2.01%) from the previous close of $3.98. The stock is currently mid-range between its 52-week high and low $2.62 and $6.61. With a market capitalization of about $179.14 million, KORU Medical Systems, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.42). Key stats such as the average daily volume over the past year has been around 156.40 thousand shares, in line with its 52-week average. Headquartered in Mahwah, NY, KORU Medical Systems, Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Linda Tharby, the company employs approximately 80 people and listed since April 05, 1994. KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally.

KORU Medical Systems, Inc. trades at a P/E ratio of -80.17, slightly below the S&P 500 average, with a price-to-sales ratio of 4.18 and a price-to-book ratio of 10.8 reflecting a rich premium to book value. The P/FCF stands at 1009.4, also above market averages. Compared to sector medians, KORU Medical Systems, Inc. P/S is broadly in line with the sector, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

KORU Medical Systems, Inc. (NASDAQ:KRMD) shares are flat -3.96% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows KORU Medical Systems, Inc. trading at a premium to the broader market with a P/E of -80.17. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $7.00, suggesting 79.49% upside. Our AI forecast model points to short-term weakness (-1.79% over two weeks), a medium-term rise (91.03% over three months), and a longer-term gain (206.15% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that KORU Medical Systems, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.79%, with price expected at $3.83 by May 29, 2026, within a range of $3.71 to $3.96 3-Month Outlook: Projected rise of 91.03%, reaching $7.45 by August 13, 2026, with a range of $7.30 to $7.60. 1-Year Outlook: Projected gain of 206.15%, with price at $11.94 by May 14, 2027, within a range of $5.58 to $16.50.